Ibaraki, Japan

Yumiko Tokusumi

This inventor holds 1 USPTO granted patent. Top assignee: Dna Vec Research Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumiko Tokusumi. Retrieved from https://idiyas.com/inventor/yumiko-tokusumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yumiko Tokusumi: Innovator in Gene Therapy

Introduction

Yumiko Tokusumi is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of gene therapy through her innovative research and development of viral vectors. Her work focuses on the Paramyxoviridae family of viruses, which has important implications for medical applications.

Latest Patents

Yumiko holds a patent for an "Envelope gene-deficient Paramyxovirus vector." This patent describes the successful recovery of F gene-deficient virus virions using an F gene-deficient Sendai virus genomic cDNA. Furthermore, infectious viral particles deficient in the F gene are constructed using F-expressing cells as helper cells. The patent also details the recovery of F gene and HN gene-deficient virus virions, as well as the production of infectious viral particles using F- and HN-expressing cells. Additionally, the construction of a virus deficient in both the F gene and HN gene is achieved, along with the production of M gene-deficient infectious virus particles. These techniques contribute significantly to the development of vectors of Paramyxoviridae that are usable in gene therapy.

Career Highlights

Yumiko Tokusumi is associated with Dna Vec Research Inc., where she continues to advance her research in viral vectors. Her innovative approaches have positioned her as a key figure in the field of gene therapy, particularly in the development of viral vectors that can be utilized for therapeutic purposes.

Collaborations

Yumiko collaborates with notable colleagues, including Kaio Kitazato and Tsugumine Shu. Their combined expertise enhances the research efforts at Dna Vec Research Inc. and contributes to the advancement of gene therapy technologies.

Conclusion

Yumiko Tokusumi's work in developing gene-deficient Paramyxovirus vectors represents a significant advancement in gene therapy. Her innovative research and collaborations continue to pave the way for future breakthroughs in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…